Aprea Therapeutics, Inc. Increase (Decrease) in Accrued Liabilities
Aprea Therapeutics, Inc. (APRE) reported Increase (Decrease) in Accrued Liabilities of $136.10 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2026-08-12
- Aprea Therapeutics, Inc. increase (decrease) in accrued liabilities for the quarter ending 2026-06-30 was -$82.00K.
- Aprea Therapeutics, Inc. increase (decrease) in accrued liabilities for the quarter ending 2026-03-31 was $218.10K, a 1220.16% increase year-over-year.
- Aprea Therapeutics, Inc. increase (decrease) in accrued liabilities for the quarter ending 2025-12-31 was -$1.14K.
- Aprea Therapeutics, Inc. increase (decrease) in accrued liabilities for the quarter ending 2025-09-30 was $60.33K, a 83.55% decline year-over-year.
- Aprea Therapeutics, Inc. increase (decrease) in accrued liabilities for fiscal 2025 was -$64.49K.
- Aprea Therapeutics, Inc. increase (decrease) in accrued liabilities for fiscal 2024 was -$115.54K.
- Aprea Therapeutics, Inc. increase (decrease) in accrued liabilities for fiscal 2023 was -$189.72K.
- Aprea Therapeutics, Inc. increase (decrease) in accrued liabilities for fiscal 2022 was -$2.90M.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$82.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $136.10K 10-Q · filed 2026-08-12 | $134.97K derived: sum of 3 quarters · filed 2026-08-12 | $195.29K derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $218.10K 10-Q · filed 2026-05-13 | $216.97K derived: sum of 2 quarters · filed 2026-05-13 | $277.30K derived: sum of 3 quarters · filed 2026-05-13 | $137.09K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | -$1.14K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $59.19K derived: sum of 2 quarters · filed 2026-03-16 | -$81.01K derived: sum of 3 quarters · filed 2026-08-12 | -$64.49K 10-K · filed 2026-03-16 |
| 2025-09-30 | $60.33K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$79.87K derived: sum of 2 quarters · filed 2026-08-12 | -$63.35K 10-Q · filed 2025-11-12 | -$478.28K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | -$140.20K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$123.68K 10-Q · filed 2026-08-12 | -$538.61K derived: sum of 3 quarters · filed 2026-08-12 | -$171.75K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $16.52K 10-Q · filed 2026-05-13 | -$398.41K derived: sum of 2 quarters · filed 2026-05-13 | -$31.55K derived: sum of 3 quarters · filed 2026-05-13 | $545.41K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | -$414.93K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | -$48.07K derived: sum of 2 quarters · filed 2026-03-16 | $528.89K derived: sum of 3 quarters · filed 2026-03-16 | -$115.54K 10-K · filed 2026-03-16 |
| 2024-09-30 | $366.86K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $943.81K derived: sum of 2 quarters · filed 2025-11-12 | $299.39K 10-Q · filed 2025-11-12 | -$872.90K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $576.96K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$67.47K 10-Q · filed 2025-08-12 | -$1.24M derived: sum of 3 quarters · filed 2025-08-12 | -$756.71K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | -$644.43K 10-Q · filed 2025-05-14 | -$1.82M derived: sum of 2 quarters · filed 2025-05-14 | -$1.33M derived: sum of 3 quarters · filed 2025-05-14 | -$1.88M derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | -$1.17M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-25 | -$689.24K derived: sum of 2 quarters · filed 2025-03-25 | -$1.23M derived: sum of 3 quarters · filed 2025-03-25 | -$189.72K 10-K · filed 2025-03-25 |
| 2023-09-30 | $483.05K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$60.47K derived: sum of 2 quarters · filed 2024-11-07 | $982.56K 10-Q · filed 2024-11-07 | $589.37K derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | -$543.51K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $499.52K 10-Q · filed 2024-08-12 | $106.32K derived: sum of 3 quarters · filed 2024-08-12 | -$647.44K derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | $1.04M 10-Q · filed 2024-05-14 | $649.84K derived: sum of 2 quarters · filed 2024-05-14 | -$103.93K derived: sum of 3 quarters · filed 2024-05-14 | -$1.02M derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | -$393.19K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26 | -$1.15M derived: sum of 2 quarters · filed 2024-03-26 | -$2.06M derived: sum of 3 quarters · filed 2024-03-26 | -$2.90M 10-K · filed 2024-03-26 |
| 2022-09-30 | -$753.76K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$1.67M derived: sum of 2 quarters · filed 2023-11-09 | -$2.51M 10-Q · filed 2023-11-09 | -$3.42M derived: sum of 4 quarters · filed 2024-03-26 |
| 2022-06-30 | -$916.12K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$1.76M 10-Q · filed 2023-08-10 | -$2.67M derived: sum of 3 quarters · filed 2024-03-26 | -$4.44M derived: sum of 4 quarters · filed 2024-03-26 |
| 2022-03-31 | -$840.38K 10-Q · filed 2023-05-15 | -$1.75M derived: sum of 2 quarters · filed 2024-03-26 | -$3.52M derived: sum of 3 quarters · filed 2024-03-26 | -$3.02M derived: sum of 4 quarters · filed 2024-03-26 |
| 2021-12-31 | -$914.43K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26 | -$2.68M derived: sum of 2 quarters · filed 2024-03-26 | -$2.18M derived: sum of 3 quarters · filed 2024-03-26 | -$5.22M 10-K · filed 2024-03-26 |
| 2021-09-30 | -$1.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$1.27M derived: sum of 2 quarters · filed 2022-11-09 | -$4.30M 10-Q · filed 2022-11-09 | -$2.82M derived: sum of 4 quarters · filed 2023-03-30 |
| 2021-06-30 | $505.05K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | -$2.53M 10-Q · filed 2022-08-12 | -$1.05M derived: sum of 3 quarters · filed 2023-03-30 | -$790.34K derived: sum of 4 quarters · filed 2023-03-30 |
| 2021-03-31 | -$3.04M 10-Q · filed 2022-05-16 | -$1.55M derived: sum of 2 quarters · filed 2023-03-30 | -$1.30M derived: sum of 3 quarters · filed 2023-03-30 | -$766.29K derived: sum of 4 quarters · filed 2023-03-30 |
| 2020-12-31 | $1.49M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $1.74M derived: sum of 2 quarters · filed 2023-03-30 | $2.27M derived: sum of 3 quarters · filed 2023-03-30 | $3.93M 10-K · filed 2023-03-30 |
| 2020-09-30 | $256.53K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $785.62K derived: sum of 2 quarters · filed 2021-11-08 | $2.44M 10-Q · filed 2021-11-08 | $2.84M derived: sum of 4 quarters · filed 2022-03-15 |
| 2020-06-30 | $529.09K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $2.19M 10-Q · filed 2021-08-12 | $2.59M derived: sum of 3 quarters · filed 2022-03-15 | $5.47M derived: sum of 4 quarters · filed 2022-03-15 |
| 2020-03-31 | $1.66M 10-Q · filed 2021-05-06 | $2.06M derived: sum of 2 quarters · filed 2022-03-15 | $4.94M derived: sum of 3 quarters · filed 2022-03-15 | $5.32M derived: sum of 4 quarters · filed 2022-03-15 |
| 2019-12-31 | $401.88K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $3.28M derived: sum of 2 quarters · filed 2022-03-15 | $3.66M derived: sum of 3 quarters · filed 2022-03-15 | $3.51M 10-K · filed 2022-03-15 |
| 2019-09-30 | $2.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $3.26M derived: sum of 2 quarters · filed 2020-11-06 | $3.11M 10-Q · filed 2020-11-06 | $3.75M derived: sum of 4 quarters · filed 2021-03-16 |
| 2019-06-30 | $378.23K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11 | $232.68K 10-Q · filed 2020-08-11 | $872.48K derived: sum of 3 quarters · filed 2021-03-16 | |
| 2019-03-31 | -$145.56K 10-Q · filed 2020-05-15 | $494.25K derived: sum of 2 quarters · filed 2021-03-16 | ||
| 2018-12-31 | $639.80K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $706.92K 10-K · filed 2021-03-16 | ||
| 2018-09-30 | $67.12K 10-Q · filed 2019-11-14 | |||
| 2017-12-31 | $1.12M 10-K · filed 2020-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |